45 CFR § 180 compliance
D · 65
This hospital published part of what § 180 requires.
●Machine-readable file published
●Gross / standard charges
●Discounted cash price
○Payer-specific negotiated rates
○Min / max negotiated charges
●Free, public, no login required
Procedures listed
4,794
Insurances with rates
4
CPT / HCPCS codes
2,728
Source MRF
Most expensive procedures (gross)
| Code | Description | Gross | Cash | Min payer | Max payer | # insurers |
|---|---|---|---|---|---|---|
| J1411 | etranacogene dezaparvovec-drlb 1x10exp13 gc/mL Susp 1 Each KIT | $8,400,005 | $3,276,002 | — | — | 0 |
| Q2054 | lisocabtagene maraleuceL 1.5 x to 70 x 10exp6 cell/mL Susp 1 Each VIAL | $1,472,908 | $574,434 | — | — | 0 |
| J2326 | nusinersen (PF) 12 mg/5 mL Soln 5 mL VIAL | $386,234 | $150,631 | — | — | 0 |
| J0225 | vutrisiran 25 mg/0.5 mL Syringe 0.5 mL SYRINGE | $315,092 | $122,886 | — | — | 0 |
| J1412 | valoctocogene roxaparvovc-rvox 2 x 10exp13 vg/mL Susp 1 Each VIAL | $250,132 | $97,551 | — | — | 0 |
| A9513 | lutetium Lu 177 dotatate 10 mCi/mL (370 MBq/mL) Soln 1 Each VIAL | $193,133 | $75,322 | — | — | 0 |
| J7174 | fitusiran 20 mg/0.2 mL Soln 0.2 mL VIAL | $185,938 | $72,516 | — | — | 0 |
| Q2043 | sipuleuceL-T in LR 50 million cell/250 mL Susp 250 mL BAG | $180,340 | $70,333 | — | — | 1 |
| J0224 | lumasiran 94.5 mg/0.5 mL Soln 0.5 mL VIAL | $173,090 | $67,505 | — | — | 0 |
| J1747 | Spesolimab-sbzo 60 mg/mL Soln 7.5 mL VIAL | $160,728 | $62,684 | — | — | 0 |
| A9607 | "lutetium Lu-177 vipivotide tetraxetan 27 mCi/mL (1,000 MBq/mL) Soln 1 Each VIAL" | $147,409 | $57,490 | — | — | 0 |
| J7352 | afamelanotide 16 mg Implant 1 Each VIAL | $145,183 | $56,622 | — | — | 0 |
| J9226 | histrelin 50 mg (65 mcg/day) Kit 1 Each KIT | $144,528 | $56,366 | — | — | 1 |
| 90288 | botulism immune globulin (human) 100 mg Recon soln 1 Each VIAL | $137,525 | $53,635 | — | — | 0 |
| J1823 | inebilizumab-cdon 10 mg/mL Soln 10 mL VIAL | $134,644 | $52,511 | — | — | 0 |
| 187001050 | sodium benzoate-sod phenylacet 10-10 % Soln 50 mL VIAL | $131,508 | $51,288 | — | — | 0 |
| J0223 | givosiran 189 mg/mL Soln 1 mL VIAL | $126,420 | $49,304 | — | — | 0 |
| C9293 | "glucarpidase 1,000 unit Recon soln 1 Each VIAL" | $124,516 | $48,561 | — | — | 1 |
| J9347 | tremelimumab-actl 20 mg/mL Soln 15 mL VIAL | $119,240 | $46,504 | — | — | 0 |
| J2351 | "ocrelizumab-hyaluronidase-ocsq 920 mg-23,000 unit/23 mL Soln 23 mL VIAL" | $118,897 | $46,370 | — | — | 0 |
| J9228 | ipilimumab 200 mg/40 mL (5 mg/mL) Soln 40 mL VIAL | $104,355 | $40,699 | — | — | 1 |
| J9269 | "tagraxofusp-erzs 1,000 mcg/mL Soln 1 mL VIAL" | $97,264 | $37,933 | — | — | 0 |
| J2507 | pegloticase 8 mg/mL Soln 1 mL VIAL | $88,545 | $34,532 | — | — | 1 |
| A9606 | "radium Ra 223 dichloride 1,100 kBq/mL(30 microcurie/mL) Soln 1 Each VIAL" | $86,651 | $33,794 | — | — | 1 |
| J9118 | calaspargase pegol-mknl 750 unit/mL Soln 5 mL VIAL | $85,760 | $33,446 | — | — | 0 |
| J0202 | alemtuzumab 12 mg/1.2 mL Soln 1.2 mL VIAL | $85,668 | $33,411 | — | — | 1 |
| 187552560 | Bexarotene 1 % Gel 60 g TUBE | $83,983 | $32,753 | — | — | 0 |
| J9359 | loncastuximab tesirine-lpyL 10 mg Recon soln 1 Each VIAL | $81,612 | $31,829 | — | — | 0 |
| J9266 | pegaspargase 750 unit/mL Soln 5 mL VIAL | $79,203 | $30,889 | — | — | 1 |
| J1951 | leuprolide (pediatric 6 month) 45 mg Syringe 1 Each SYRINGE | $79,041 | $30,826 | — | — | 0 |
| J9348 | naxitamab-gqgk 4 mg/mL Soln 10 mL VIAL | $75,115 | $29,295 | — | — | 0 |
| J9281 | mitoMYcin 40 mg x 2 Kit 1 Each VIAL | $73,287 | $28,582 | — | — | 0 |
| J3401 | Beremagene geperpavec-svdt 5 x 10exp9 PFU/2.5 mL Gel 2.5 mL VIAL | $72,667 | $28,340 | — | — | 0 |
| 187000714 | ribavirin 6 gram Recon soln 4 Each VIAL | $71,893 | $28,038 | — | — | 0 |
| 173091301 | belantamab mafodotin-blmf 70 mg Recon soln 1 Each VIAL | $69,165 | $26,974 | — | — | 0 |
| J1303 | ravulizumab-cwvz 100 mg/mL Soln 11 mL VIAL | $68,984 | $26,904 | — | — | 0 |
| J9229 | inotuzumab ozogamicin 0.9 mg (0.25 mg/mL initial) Recon soln 1 Each VIAL | $68,923 | $26,880 | — | — | 0 |
| J9600 | porfimer 75 mg Recon soln 1 Each VIAL | $67,175 | $26,198 | — | — | 1 |
| J2327 | risankizumab-rzaa 150 mg/mL Pen injector 1 mL SYRINGE | $64,469 | $25,143 | — | — | 0 |
| J3316 | triptorelin 22.5 mg Recon susp 1 Each VIAL | $64,262 | $25,062 | — | — | 0 |
| J0638 | canakinumab (PF) 150 mg/mL Soln 1 mL VIAL | $61,592 | $24,021 | — | — | 1 |
| J9274 | tebentafusp-tebn 100 mcg/0.5 mL Soln 0.5 mL VIAL | $60,496 | $23,594 | — | — | 0 |
| J2502 | pasireotide 10 mg Recon susp 1 Each VIAL | $60,260 | $23,502 | — | — | 1 |
| J2350 | ocrelizumab 30 mg/mL Soln 10 mL VIAL | $59,451 | $23,186 | — | — | 0 |
| 81521 | ONC BREAST MRNA MICRORA GENE XPRSN PRFL 70 GENES | $57,721 | $22,511 | — | — | 1 |
| 81541 | ONC PRST8 MRNA GENE XPRSN PRFL RT-PCR 46 GENES | $57,721 | $22,511 | — | — | 1 |
| J1961 | lenacapavir 309 mg/mL Soln 1.5 mL VIAL | $56,165 | $21,904 | — | — | 0 |
| J7311 | Fluocinolone 0.59 mg Implant 1 Each PACKET | $54,797 | $21,371 | — | — | 1 |
| J9309 | polatuzumab vedotin-piiq 140 mg Recon soln 1 Each VIAL | $53,646 | $20,922 | — | — | 0 |
| J3241 | teprotumumab-trbw 500 mg Recon soln 1 Each VIAL | $51,900 | $20,241 | — | — | 0 |
Showing top 50 of 4,794 priced procedures, sorted by gross charge.
Data straight from this hospital's federally-mandated machine-readable file (45 CFR § 180). The compliance grade reflects how completely the hospital published the six required data elements, not the quality of care.